On May 7, 2025, The Oncology Institute, Inc. held its Annual Meeting where shareholders elected eight directors, ratified BDO USA, LLP as accountants, and approved a possible reverse stock split ratio of 1-for-5 to 1-for-40. A total of 61,891,379 shares were voted, representing 81.70% of outstanding shares.